Latest filing published 07 Jun 2024 for Syros Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Andrew M. Oh: trading record in brief
Andrew M. Oh discloses dealings in Syros Pharmaceuticals, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 16 September 2022 to 5 June 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 7 June 2024: a share grant, in Syros Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Andrew M. Oh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,000 shares0Common StockSEC:0000950170-24-070703:0
- 4,000 shares0Common StockSEC:0001209191-23-033729:0
- 8,000 shares0Common StockSEC:0001209191-22-050556:0
3 of 3 declarations
